Liver diseases, including non-alcoholic steatohepatitis (NASH) are still a significant and growing burden on healthcare systems worldwide. Here’s an updated overview: NASH and Liver Diseases Are Increasing NASH, a progressive form of non-alcoholic fatty liver disease (NAFLD), is rising in parallel with obesity, type 2 diabetes, and metabolic syndrome. NAFLD affects nearly 25–30% of the […]
Patients and caregivers need to handle Retinal Vein Occlusion (RVO) and Retinal Artery Occlusion (RAO) with care. These are two serious eye conditions that can cause sudden vision loss. Understanding the Conditions Retinal Vein Occlusion (RVO) Definition: Blockage of a vein carrying blood away from the retina, leading to fluid leakage and swelling. Types: Central
Retinal Vein Occlusion (RVO) and Retinal Artery Occlusion (RAO) represent a significant burden on healthcare systems; both clinically and economically, though the degree varies by condition. Retinal Vein Occlusion (RVO) Most common term for a blood clot in the eye. Occurs when a vein in the retina becomes blocked, usually by a thrombus. Two main
Retinal Vein Occlusion (RVO) and Retinal Artery Occlusion (RAO) Read More »
Depression is a common and serious mental health condition that affects how the patient feel, think, and acts. It goes beyond just feeling sad or going through a rough patch. It’s a persistent feeling of sadness or a lack of interest or pleasure in activities that you normally enjoy, lasting for weeks or more. Common
Depression remains a significant burden on healthcare systems worldwide in 2025. Despite growing awareness and improvements in mental health treatment, several key factors contribute to its ongoing impact: High prevalence: Depression continues to affect hundreds of millions globally. According to the World Health Organization, it is one of the leading causes of disability. Economic cost:
Recent advancements in prostate cancer clinical research have introduced promising therapies, diagnostic tools, and surgical techniques aimed at improving patient outcomes. Here’s an overview of the most notable developments: Emerging Therapies and Combination Treatments Poly Adenosine Diphosphate Ribose Polymerase (PARP) Inhibitor Combinations: A Northwestern Medicine-led trial demonstrated that combining abiraterone/prednisone with the PARP inhibitor olaparib
Recent Advancements in Prostate Cancer Clinical Research Read More »
Prostate cancer is a common type of cancer in men, especially older men, and understanding the disease helps both patients and caregivers manage it more effectively. Understanding Prostate Cancer What it is: A cancer that forms in the prostate gland, which is part of the male reproductive system. Risk factors: Age (especially over 50), family
Prostate cancer remains a significant burden on healthcare systems around the world. Here’s why: Prevalence and Incidence Prostate cancer is one of the most diagnosed cancers in men. In countries with aging populations (like the U.S., Canada, the United Kingdom, and much of Europe), incidence rates are rising due to both increased life expectancy
Benign Prostate Hyperplasia (BPH), also known as enlarged prostate, is a common condition that affects many men as they age. Here’s the patients and caregivers care plan: What is BPH? BPH is a non-cancerous enlargement of the prostate gland, which is located just below the bladder and surrounds the urethra (the tube that carries urine
Benign Prostate Hyperplasia (BPH) represents a significant burden on healthcare systems worldwide, particularly in aging populations. Here’s a quick breakdown of why: Prevalence and Demographics Common in older men: BPH affects up to 50% of men by age 60 and up to 90% by age 85. As life expectancy increases, the number of men requiring
